Femasys Q2 net loss $4.47M; raises $30M private placement, regains Nasdaq compliance

FEMASYS INC

Q2 2026 sales $331,827, down 18.9% YoY; net loss $4,469,095 ($1.33/share) vs $4,585,922 ($3.18/share) in Q2 2025.
Six-month sales $756,716 (+0.8% YoY); net loss $3,622,995 ($1.08/share) vs $10,482,761 ($7.76/share) in H1 2025.
Cash $1.4M at June 30; completed $30M private placement with potential $90M from warrant exercise.
Regained Nasdaq compliance; received CE Mark for FemHSG; launched FemaSeed Complete at ACOG 2026.
Appointed John Canning as COO; partnership with AMI Technologies for Israel commercialization.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.